Teva Recalls Mesalamine Tablets Due to Dissolution Test Failures
Teva Pharmaceuticals USA is recalling 3,695 bottles of Mesalamine Delayed-Release Tablets because stability testing showed low dissolution results.
- Product
- MESALAMINE — MESALAMINE (MESALAMINE)
- Category
- Drug
- Distribution
- Distributed nationwide